文献速递呼吸道感染间质性肺疾病

结节病并发慢性肺曲霉病:一项单中心回顾性研究

Chronic pulmonary aspergillosis complicating sarcoidosis.
PubMed 文献 · Eur Respir J · 2017-06-15

该研究回顾性分析了1980至2015年间65例结节病合并慢性肺曲霉病(CPA-SA)患者,多数为基础结节病已进展至纤维囊性期。CPA-SA患者死亡率高,但死因多为进展性结节病本身而非CPA;CPI、纤维化范围和肺动脉高压可预测生存。

要点

  • CPA多发生于晚期纤维囊性结节病患者,CCPA为最常见类型。
  • CPA-SA患者死亡率高,但死亡主要归因于基础结节病进展而非CPA。
  • CPI、纤维化范围和肺动脉高压是预测生存的关键因素。

核心结论

  • CPA发生于晚期结节病,CPA-SA死亡率高主要源于基础结节病进展而非CPA本身。
  • CPI、纤维化范围和肺动脉高压最能预测CPA-SA患者的生存。

研究设计与样本

  • 回顾性单中心研究,纳入1980至2015年间65例结节病合并CPA患者(44例男性)。
  • 诊断结节病时年龄41.4±13.5岁,诊断CPA时年龄48.3±11.9岁。

主要发现

  • 41例(63%)接受结节病治疗(糖皮质激素或免疫抑制剂)。
  • 慢性空洞性肺曲霉病(CCPA)为最常见的CPA类型。
  • 27例(41.5%)死亡,平均死亡年龄55.8岁;5年生存率73%,10年生存率61%。
  • 死亡多因晚期结节病,罕因咯血;与配对无CPA健康对照相比生存无差异,但 mould 高风险暴露比例更高。

关键数值与推荐

  • 55例需长期抗真菌治疗,14例需介入放射学,11例需切除手术,2例需移植。
  • CPI、纤维化范围和肺动脉高压可预测生存。

临床怎么用

  • 对晚期纤维囊性结节病患者应警惕CPA发生,尤其存在高风险 mould 暴露时。
  • 评估预后时应关注CPI、纤维化范围和肺动脉高压,而非仅关注CPA本身。
  • 治疗需兼顾结节病基础进展与CPA管理,部分患者需长期抗真菌、介入或手术。

局限性

  • 回顾性单中心设计,样本量65例,结果外推需谨慎。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Chronic pulmonary aspergillosis (CPA) complicating sarcoidosis (SA) is associated with high mortality, and there is a lack of clarity regarding the relative contributions of SA or CPA.This was a retrospective single-centre study on CPA-SA.In total, 65 patients (44 men), aged 41.4±13.5 and 48.3±11.9 years at the time of SA and CPA diagnoses, respectively, were included between 1980 and 2015. Of these, 64 had fibrocystic SA, most often advanced, with composite physiological index (CPI) >40 (65% of patients) and pulmonary hypertension (PH) (31%), and 41 patients (63%) were treated for SA (corticosteroids or immunosuppressive drugs). Chronic cavitary pulmonary aspergillosis (CCPA) was the most frequent CPA pattern. Regarding treatment, 55 patients required long-term antifungals, 14 interventional radiology, 11 resection surgery and two transplantation. Nearly half of the patients (27; 41.5%) died (mean age 55.8 years); 73% of the patients achieved 5-year survival and 61% 10-year survival. Death most often resulted from advanced SA and rarely from haemoptysis. CPI, fibrosis extent and PH predicted survival. Comparison with paired healthy controls without CPA did not show any difference in survival, but a higher percentage of patients had high-risk mould exposure.CPA occurs in advanced pulmonary SA. CPA-SA is associated with high mortality due to the underlying advanced SA rather than to the CPA. CPI, fibrosis extent and PH best predict outcome.

来源:Eur Respir J,查看原文。版权归原作者所有。

引用

  1. Uzunhan Y, Nunes H, Jeny F, et al. Chronic pulmonary aspergillosis complicating sarcoidosis. Eur Respir J. 2017. PMID: 28619957. doi:10.1183/13993003.02396-2016

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。